NCT00993304
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Aarhus C, Denmark
Clinical trial condition
Diabetes
Explore clinical trials studying Diabetes. Study availability and eligibility vary by location and protocol.
2,489 public trials
175 recruiting studies
Diabetes trial results
NCT00943501
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Cypress, California, United States
- Novo Nordisk Investigational Site Los Angeles, California, United States
- Novo Nordisk Investigational Site Los Angeles, California, United States
- Novo Nordisk Investigational Site Aurora, Colorado, United States
NCT00873223
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Chula Vista, California, United States
Completed
Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes
NCT01288326
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Brussels, Belgium
NCT01517555
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Neuss, Germany
NCT01511198
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Vestavia Hills, Alabama, United States
- Novo Nordisk Investigational Site Tucson, Arizona, United States
- Novo Nordisk Investigational Site Carlisle, Arkansas, United States
- Novo Nordisk Investigational Site Jonesboro, Arkansas, United States
NCT00761540
- Conditions
- Diabetes, Diabetes Mellitus, Endocrine System Diseases, +4 more
- Locations
-
- Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
Completed
Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes
NCT01511692
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Adelaide, South Australia, Australia
- Novo Nordisk Investigational Site Neuss, Germany
NCT01518166
- Conditions
- Diabetes, Diabetes Mellitus, Endocrine System Diseases, +4 more
- Locations
-
- Novo Nordisk Investigational Site Uppsala, Sweden
NCT01615978
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan